Louis P. Lacasse

Louis P.
Lacasse currently works at Centre For Commercialization of Cancer Immunotherapy, as Chairman, Aegera Therapeutics, Inc., as Director, Bellus Health (Innodia), Inc., as Director, AgeChem Financial, Inc., as Director, and GeneChem Management, Inc., as General Partner from 1997.
Mr. Lacasse also formerly worked at AmpliPhi Biosciences Corp., as Director from 1998 to 2006, Aptalis Pharma Canada ULC, as Director, Warnex, Inc., as Independent Director from 2012 to 2013, Chromos Molecular Systems, Inc., as Director, Idun Pharmaceuticals, Inc., as Director, Advitech, Inc., as Director from 2009 to 2011, Conatus Pharmaceuticals, Inc., as Independent Non-Executive Director from 2013 to 2016, Biochem Pharma, Inc., as Director, Mirati Therapeutics, Inc., as Independent Director in 2012, Emerillon Therapeutics, Inc., as Director, Alethia Biotherapeutics, Inc., as Director, Calyx Ventures, Inc., as Independent Director from 2012 to 2013, Natunola AgriTech, Inc., as Director, Nuchem Therapeutics, Inc., as Director, Bank of Montreal, as Account Manager, National Bank of Canada, as Financial Analyst from 1978 to 1979, The Caisse de dépôt et placement du Québec, as Vice President in 1997, SOFINOV Société Financière d'Innovation, Inc., as Vice President-Healthcare & Biotechnology from 1987 to 1997, and CDP Capital Private Equity, as Vice President from 1988 to 1997.
Mr. Lacasse received his Masters Business Admin degree from McGill University and undergraduate degree from École des Hautes Études Commerciales de Paris.